RU2378008C2 - Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку - Google Patents
Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку Download PDFInfo
- Publication number
- RU2378008C2 RU2378008C2 RU2004136295/15A RU2004136295A RU2378008C2 RU 2378008 C2 RU2378008 C2 RU 2378008C2 RU 2004136295/15 A RU2004136295/15 A RU 2004136295/15A RU 2004136295 A RU2004136295 A RU 2004136295A RU 2378008 C2 RU2378008 C2 RU 2378008C2
- Authority
- RU
- Russia
- Prior art keywords
- antigen
- composition according
- carrier protein
- conjugated
- composition
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38067502P | 2002-05-14 | 2002-05-14 | |
| US60/380,675 | 2002-05-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2004136295A RU2004136295A (ru) | 2006-03-20 |
| RU2378008C2 true RU2378008C2 (ru) | 2010-01-10 |
Family
ID=29420626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004136295/15A RU2378008C2 (ru) | 2002-05-14 | 2003-05-14 | Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20060147466A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1506007B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4662537B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN1816350B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE513560T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003239744B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0310042A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2485999C (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04011248A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ536859A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2378008C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003094960A2 (cg-RX-API-DMAC7.html) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2619176C2 (ru) * | 2011-05-11 | 2017-05-12 | Чилдрен'С Медикал Сентер Корпорейшн | Иммуногенная композиция презентации множественных антигенов, относящиеся к ней способы и применения |
| RU2704452C1 (ru) * | 2019-04-22 | 2019-10-28 | Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства | Способ получения вакцины гемофильной тип b конъюгированной |
| US11013793B2 (en) | 2018-09-12 | 2021-05-25 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
| US11612647B2 (en) | 2017-06-23 | 2023-03-28 | University Of Maryland, Baltimore | Immunogenic compositions |
| US12036276B2 (en) | 2021-09-09 | 2024-07-16 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
| US12129283B2 (en) | 2018-09-12 | 2024-10-29 | The Children's Medical Center Corporation | Pneumococcal fusion protein vaccines |
| RU2865485C2 (ru) * | 2021-03-30 | 2026-07-06 | Дзе Юниверсити Оф Токио | Вакцина с наногелевым покрытием |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| DK1587537T3 (da) | 2003-01-30 | 2012-07-16 | Novartis Ag | Injicerbare vacciner mod multiple meningococ-serogrupper |
| AU2011224064A1 (en) * | 2003-10-02 | 2011-10-06 | Novartis Vaccines And Diagnostics S.R.L. | Liquid vaccines for multiple meningococcal serogroups |
| GB0500787D0 (en) | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| RU2379052C2 (ru) | 2004-04-30 | 2010-01-20 | Чирон С.Р.Л. | Вакцинация менингококковыми конъюгатами |
| EP2269638A3 (en) * | 2004-05-28 | 2012-06-13 | GlaxoSmithKline Biologicals S.A. | Vaccine compositions comprising virosomes and a saponin adjuvant |
| HUE045482T2 (hu) | 2005-06-27 | 2019-12-30 | Glaxosmithkline Biologicals Sa | Immunogén készítmény |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| WO2008101349A1 (en) | 2007-02-23 | 2008-08-28 | Her Majesty The Queen, In Right Of Canada, As Repesented By The Minister Of National Defence | Recombinant viral vectors for prevention and protection against alphavirus infection |
| CN101249261B (zh) * | 2008-03-18 | 2010-10-27 | 中国疾病预防控制中心病毒病预防控制所 | 一种肾综合征出血热粘膜免疫疫苗及其制备方法 |
| EP2440251A4 (en) * | 2009-06-09 | 2013-01-16 | Defyrus Inc | INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION |
| CA2808975C (en) | 2010-08-23 | 2018-10-30 | Wyeth Llc | Stable formulations of neisseria meningitidis rlp2086 antigens |
| KR101584871B1 (ko) | 2010-09-10 | 2016-01-22 | 와이어쓰 엘엘씨 | 네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체 |
| CA2865745C (en) | 2012-03-09 | 2018-01-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| EP4272750A3 (en) | 2013-02-07 | 2024-01-24 | Children's Medical Center, Corp. | Protein antigens that provide protection against pneumococcal colonization and/or disease |
| CA2903716C (en) | 2013-03-08 | 2019-04-09 | Pfizer Inc. | Immunogenic fusion polypeptides |
| RU2662968C2 (ru) | 2013-09-08 | 2018-07-31 | Пфайзер Инк. | Иммуногенная композиция против neisseria meningitidis (варианты) |
| CN104383531A (zh) * | 2014-11-18 | 2015-03-04 | 北京智飞绿竹生物制药有限公司 | 预防儿童脑膜炎的联合疫苗及其制备方法 |
| KR20190049940A (ko) | 2015-02-19 | 2019-05-09 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
| CN105031644A (zh) * | 2015-06-25 | 2015-11-11 | 中国科学院过程工程研究所 | 一种疫苗佐剂及含该疫苗佐剂的疫苗组合物和疫苗制剂 |
| CN106606775A (zh) * | 2015-10-27 | 2017-05-03 | 格里菲斯大学 | 脂质体a群链球菌疫苗 |
| SG11201906519RA (en) | 2017-01-31 | 2019-08-27 | Pfizer | Neisseria meningitidis compositions and methods thereof |
| EP3600400A4 (en) | 2017-03-28 | 2021-01-13 | The Children's Medical Center Corporation | MULTIPLE ANTIGEN (MAPS) BASED STAPHYLOCOCCUS AUREUS VACCINE, IMMUNOGENIC COMPOSITION AND USES THEREOF |
| MX2019014829A (es) | 2017-06-10 | 2020-08-17 | Inventprise Llc | Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas. |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| CA3155669A1 (en) | 2019-09-27 | 2021-04-01 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| CA3185429A1 (en) * | 2020-06-12 | 2021-12-16 | Glaxosmithkline Biologicals Sa | Bacterial immunization using nanoparticle vaccine |
| US12053515B2 (en) | 2020-08-10 | 2024-08-06 | Inventprise, Inc. | Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4459286A (en) * | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
| RU2105568C1 (ru) * | 1989-12-14 | 1998-02-27 | Нэшнл Рисерч Каунсл Оф Канада | Полисахарид neisseria meningitidis с модифицированной группой b, конъюгированный антиген, вакцина против менингита группы b и способ индукции ответа антител к менингиту группы b |
| WO1999042130A1 (en) * | 1998-02-23 | 1999-08-26 | Connaught Laboratories Limited | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| WO2002000249A2 (en) * | 2000-06-29 | 2002-01-03 | Glaxosmithkline Biologicals S.A. | Multivalent vaccine composition |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9326174D0 (en) * | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| GB9525083D0 (en) * | 1995-12-07 | 1996-02-07 | Danbiosyst Uk | Vaccine compositions |
| US6884435B1 (en) * | 1997-01-30 | 2005-04-26 | Chiron Corporation | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| US6818222B1 (en) * | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| GB9713156D0 (en) * | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
| EP0994723A1 (en) * | 1997-06-24 | 2000-04-26 | Chiron Corporation | Methods of immunizing adults using anti-meningococcal vaccine compositions |
| DE69939943D1 (de) * | 1998-10-21 | 2009-01-02 | Kitasato Inst | Attenuierte Toxine als Adjuvantien |
| CA2366152A1 (en) * | 1999-03-19 | 2000-09-28 | Smithkline Beecham Biologicals S.A. | Streptococcus pneumoniae vaccine |
| GB9923060D0 (en) * | 1999-09-29 | 1999-12-01 | Chiron Spa | Vaccine |
| JP3980884B2 (ja) * | 2000-02-15 | 2007-09-26 | アイディー バイオメディカル コーポレイション オブ ケベック | プロテオソーム・インフルエンザ・ワクチン |
| US20020009463A1 (en) * | 2000-02-23 | 2002-01-24 | Jan Raa | Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces |
| GB0103170D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| ES2399386T3 (es) * | 2001-04-05 | 2013-04-01 | Novartis Vaccines And Diagnostics, Inc. | Aumento de la inmunidad de las mucosas tras sensibilización parenteral |
| GB0129007D0 (en) * | 2001-12-04 | 2002-01-23 | Chiron Spa | Adjuvanted antigenic meningococcal compositions |
| ES2339762T3 (es) * | 2002-01-14 | 2010-05-25 | Novartis Vaccines And Diagnostics, Inc. | Vacuna contra el vih y procedimiento de uso. |
| GB0302218D0 (en) * | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
-
2003
- 2003-05-14 NZ NZ536859A patent/NZ536859A/en not_active IP Right Cessation
- 2003-05-14 CA CA2485999A patent/CA2485999C/en not_active Expired - Fee Related
- 2003-05-14 AT AT03732933T patent/ATE513560T1/de not_active IP Right Cessation
- 2003-05-14 BR BR0310042-1A patent/BR0310042A/pt not_active IP Right Cessation
- 2003-05-14 RU RU2004136295/15A patent/RU2378008C2/ru not_active IP Right Cessation
- 2003-05-14 US US10/514,208 patent/US20060147466A1/en not_active Abandoned
- 2003-05-14 CN CN038166593A patent/CN1816350B/zh not_active Expired - Fee Related
- 2003-05-14 AU AU2003239744A patent/AU2003239744B2/en not_active Ceased
- 2003-05-14 WO PCT/IB2003/002648 patent/WO2003094960A2/en not_active Ceased
- 2003-05-14 EP EP03732933A patent/EP1506007B1/en not_active Expired - Lifetime
- 2003-05-14 MX MXPA04011248A patent/MXPA04011248A/es active IP Right Grant
- 2003-05-14 CN CN038166585A patent/CN1684707B/zh not_active Expired - Fee Related
- 2003-05-14 JP JP2004503043A patent/JP4662537B2/ja not_active Expired - Fee Related
-
2010
- 2010-06-23 JP JP2010143117A patent/JP2010202672A/ja not_active Withdrawn
-
2011
- 2011-03-04 US US13/041,042 patent/US20110159030A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4459286A (en) * | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
| RU2105568C1 (ru) * | 1989-12-14 | 1998-02-27 | Нэшнл Рисерч Каунсл Оф Канада | Полисахарид neisseria meningitidis с модифицированной группой b, конъюгированный антиген, вакцина против менингита группы b и способ индукции ответа антител к менингиту группы b |
| WO1999042130A1 (en) * | 1998-02-23 | 1999-08-26 | Connaught Laboratories Limited | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| WO2002000249A2 (en) * | 2000-06-29 | 2002-01-03 | Glaxosmithkline Biologicals S.A. | Multivalent vaccine composition |
Non-Patent Citations (1)
| Title |
|---|
| PORRO M, A molecular model of artificial glycoprotein with predetermined multiple immunodeterminants for gram-positive and gram-negative encapsulated bacteria. MOLECULAR IMMUNOL., v.23, №4, 1986, p.385-391. UGOZZOLI M, Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant" JOURNAL OF INFECTIOUS DISEASES, vol. 183, no. 2, 15 January 2001 (2001-01-15), pages 351-354, PMID: 11110644. GIULIANI M.M., Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity" J EXP MED, 06.04.1998; 187(7): 1123-32, PMID: 9529328. * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11976097B2 (en) | 2011-05-11 | 2024-05-07 | Children's Medical Center Corporation | Modified biotin-binding protein, fusion proteins thereof and applications |
| US10017548B2 (en) | 2011-05-11 | 2018-07-10 | Children's Medical Center Corporation | Modified biotin-binding protein, fusion proteins thereof and applications |
| US12545710B2 (en) | 2011-05-11 | 2026-02-10 | Children's Medical Center Corporation | Multiple antigen presenting immunogenic composition, and methods and uses thereof |
| US10611805B2 (en) | 2011-05-11 | 2020-04-07 | Children's Medical Center Corporation | Modified biotin-binding protein, fusion proteins thereof and applications |
| US10766932B2 (en) | 2011-05-11 | 2020-09-08 | The Children's Medical Center Corporation | Multiple antigen presenting immunogenic composition, and methods and uses thereof |
| US11981708B2 (en) | 2011-05-11 | 2024-05-14 | Children's Medical Center Corporation | Multiple antigen presenting immunogenic composition, and methods and uses thereof |
| US11560410B2 (en) | 2011-05-11 | 2023-01-24 | Children's Medical Center Corporation | Modified biotin-binding protein, fusion proteins thereof and applications |
| RU2619176C2 (ru) * | 2011-05-11 | 2017-05-12 | Чилдрен'С Медикал Сентер Корпорейшн | Иммуногенная композиция презентации множественных антигенов, относящиеся к ней способы и применения |
| US11612647B2 (en) | 2017-06-23 | 2023-03-28 | University Of Maryland, Baltimore | Immunogenic compositions |
| US11701416B2 (en) | 2018-09-12 | 2023-07-18 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
| US11013793B2 (en) | 2018-09-12 | 2021-05-25 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
| US12129283B2 (en) | 2018-09-12 | 2024-10-29 | The Children's Medical Center Corporation | Pneumococcal fusion protein vaccines |
| US12370247B2 (en) | 2018-09-12 | 2025-07-29 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
| RU2704452C1 (ru) * | 2019-04-22 | 2019-10-28 | Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства | Способ получения вакцины гемофильной тип b конъюгированной |
| RU2865485C2 (ru) * | 2021-03-30 | 2026-07-06 | Дзе Юниверсити Оф Токио | Вакцина с наногелевым покрытием |
| US12036276B2 (en) | 2021-09-09 | 2024-07-16 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
| US12377140B2 (en) | 2021-09-09 | 2025-08-05 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003094960A3 (en) | 2004-03-04 |
| MXPA04011248A (es) | 2005-02-17 |
| US20060147466A1 (en) | 2006-07-06 |
| CA2485999C (en) | 2015-02-17 |
| CN1816350A (zh) | 2006-08-09 |
| BR0310042A (pt) | 2005-04-05 |
| US20110159030A1 (en) | 2011-06-30 |
| CA2485999A1 (en) | 2003-11-20 |
| AU2003239744A1 (en) | 2003-11-11 |
| AU2003239744B2 (en) | 2008-07-03 |
| RU2004136295A (ru) | 2006-03-20 |
| JP2010202672A (ja) | 2010-09-16 |
| EP1506007A2 (en) | 2005-02-16 |
| CN1816350B (zh) | 2010-11-10 |
| EP1506007B1 (en) | 2011-06-22 |
| JP4662537B2 (ja) | 2011-03-30 |
| NZ536859A (en) | 2007-11-30 |
| ATE513560T1 (de) | 2011-07-15 |
| CN1684707A (zh) | 2005-10-19 |
| JP2005526847A (ja) | 2005-09-08 |
| CN1684707B (zh) | 2012-09-05 |
| WO2003094960A2 (en) | 2003-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4662537B2 (ja) | 細菌性髄膜炎に関する粘膜組合せワクチン | |
| JP4696260B2 (ja) | キトサンアジュンバントおよび髄膜炎菌抗原を用いる粘膜ワクチン | |
| JP7275277B2 (ja) | ストレプトコッカス・ニューモニエ多糖-タンパク質コンジュゲートを含む組成物およびその使用方法 | |
| JP5075317B2 (ja) | 莢膜性多糖類の可溶化および組合せワクチン | |
| JP2010209122A (ja) | キトサンアジュンバントおよび髄膜炎菌抗原を用いる粘膜ワクチン | |
| JP2020514326A (ja) | 肺炎連鎖球菌多糖−タンパク質コンジュゲートの免疫原性の増強 | |
| JP2002508761A (ja) | Bordetella pertussis線毛を含有するワクチン接種結合体および経口ワクチンにおけるキャリアとしてのbordetella pertussis抗原 | |
| JP2001527050A (ja) | ワクチン | |
| JP5718545B2 (ja) | 髄膜炎菌結合体ワクチン接種 | |
| HK1214129A1 (zh) | 用於缀合疫苗的经过修饰的多糖 | |
| Fattom et al. | Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides | |
| JP2018518512A (ja) | 多価肺炎球菌コンジュゲートワクチン | |
| US20030099672A1 (en) | Pneumococcus polysaccharide conjugates for use as vaccine against tetanus an diphtheria | |
| CN114025784A (zh) | 用针对肺炎链球菌血清型29进行保护的免疫原性组合物治疗患者的方法 | |
| Fattom | Qualitative and quantitative immune response to bacterial capsular polysaccharides and their conjugates in mouse and man | |
| WO2002007764A1 (en) | Improvements relating to vaccines containing bordetella pertussis antigen | |
| JP2006516609A (ja) | 粘膜髄膜炎菌性ワクチン | |
| Moingeon | Challenges and Opportunities in the Development of New Conjugate Vaccines against Infectious Diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20170515 |